David Pauling's most recent trade in Sutro Biopharma Inc was a trade of 675 Common Stock done . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 675 | 10,025 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2026 | 675 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.31 per share. | 04 Mar 2026 | 277 | 9,748 (0%) | 0% | 21.3 | 5,903 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 33,600 | 33,600 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 4,200 | 4,200 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 2,356 | 10,320 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 2,356 | 7,069 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.55 per share. | 01 Mar 2026 | 970 | 9,350 (0%) | 0% | 20.6 | 19,934 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 842 | 8,515 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 842 | 1,686 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 Mar 2026 | 551 | 7,964 (0%) | 0% | 20.5 | 11,279 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 500 | 7,673 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2026 | 500 | 500 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2025 | 7,200 | 7,200 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 12,504 | 71,737 (0%) | 0% | 0.8 | 9,993 | Common Stock |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 101,500 | 101,500 | - | - | Stock Option (Right to Buy) | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 94,250 | 94,250 | - | - | Restricted Stock Units (RSUs) |